Brind.

Qiagen N.V. is a Netherlands-based holding company.

Steady: 0 in the last 7 days Updated oct 22

The latest in this situation

  1. Qiagen reported its financial results, citing both Frankfurt and New York time zones.

How it started

13 reports, 3 independent, last reported Oct 21. The briefing below covers this first event.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Qiagen N.V. is a Netherlands-based holding company.

Who's involved

What this event is mainly about
Qiagen

How it developed

Newest first. Tap a step to see who reported it.
  1. Qiagen reported its financial results, citing both Frankfurt and New York time zones.1 source
  2. Qiagen, a Netherlands-based company, announced a share offering with restrictions on persons in South Africa.Sub-event
  3. Qiagen is based in the Netherlands.1 source
  4. Qiagen N.V., a Netherlands-based holding company, announced that its bonds will be admitted to trading on the Frankfurt Stock Exchange and an Open Market.1 source
  5. U.S. and China import tariffs are impacting the profitability of Qiagen.1 source
  6. Qiagen announces new product line compatible with PacBio platforms.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • finanznachrichten.de
  • Business WireQIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds VENLO, Netherlands, August 28, 2025--(BUSINESS WIRE)--NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNI
  • Business WireQIAGEN N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds VENLO, Netherlands, August 28, 2025--(BUSINESS WIRE)--NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE
  • Business WireQIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability Q2 2025 results: Net sales of $534 million (+7% actual rates); adjusted diluted EPS of $0.60 Net sales +6% CER (constan
  • ZacksWhy Qiagen (QGEN) is a Top Growth Stock for the Long-Term For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Many investors also have
  • Business WireQIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels Expansion of QIAseq portfolio to Long Read Panels enables high-resolution analysis of complex genomic regions using long-read
  • ZacksAre You a Momentum Investor? This 1 Stock Could Be the Perfect Pick Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike. While you
  • ZacksAre You a Value Investor? This 1 Stock Could Be the Perfect Pick It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for
  • Unknown outlet
  • Unknown outlet
  • Unknown outlet
  • Unknown outlet
  • Unknown outlet